Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons

FASEB Journal

Volumn 14, Issue 9, 2000, Pages 1202-1214

  Sawada, Hideyuki ^a   Ibi, Masakazu ^a   Kihara, Takeshi ^a   Urushitani, Makoto ^a   Honda, Kazuhiro ^a   Nakanishi, Miki ^a   Akaike, Akinori ^a   Shimohama, Shun ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

AP 1 element; Estrogen receptor ; Neuroprotection; Parkinson's disease

Indexed keywords

BLEOMYCIN SULFATE; BUTHIONINE SULFOXIMINE; CASPASE INHIBITOR; ESTRADIOL; ESTRADIOL RECEPTOR; ESTROGEN DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; ENZYME INHIBITION; HORMONE ACTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; TRANSCRIPTION REGULATION;

EID: 0034118659     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.14.9.1202     Document Type: Article

References (72)

1. Fahn, S., and Cohen, G. (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32, 804-812
2. Tan, S., Wood, M., and Maher, P. (1998) Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J. Neurochem. 71, 95-105
3. Ratan, R. R., Murphy, T. H., and Baraban, J. M. (1994) Oxidative stress induces apoptosis in embryonic cortical neurons. J. Neurochem. 62, 376-379
4. Mochizuki, H., Goto, K., Mori, H., and Mizuno, Y. (1996) Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137, 120-123
5. Hunot, S., Brugg, B., Ricard, D., Michel, P. P., Muriel, M. P., Ruberg, M., Faucheux, B. A., Agid, Y., and Hirsch, E. C. (1997) Nuclear translocation of NK-κB is increased in dopaminergic neurons of patients with Parkinson disease. Proc. Natl. Acad. Sci. USA 94, 7531-7536
6. Mayeux, R., Marder, K., Cote, L. J., Denaro, J., Hemenegildo, N., Mejia, H., Tang, M. X., Lantigua, R., Wilder, D., and Gurland, B. (1995) The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am. J. Epidemiol. 142, 820-827
7. Bauer, R. B., Stevens, C., Reveno, W. S., and Rosenbaum, H. (1982) L-dopa treatment of Parkinson's disease: a ten-year follow up study. J. Am. Geriatr. Soc. 30, 322-325
8. Li, S. C., Schoenberg, B. S., Wang, C. C., Cheng, X. M., Rui, D. Y., Bolis, C. L., and Schoenberg, D. G. (1985) A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China. Arch. Neurol. 42, 655-657
9. Pollard, J. W., Pacey, J., Cheng, S. V., and Jordan, E. G. (1987) Estrogens and cell death in murine uterine luminal epithelium. Cell Tissue Res. 249, 533-540
10. Kyprianou, N., English, H. F., Davidson, N. E., and Isaacs, J. T. (1991) Programmed cell death during regression of the MCF-7 human breast cancer after estrogen ablation. Cancer Res. 51, 162-166
11. Tang, M. X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., and Mayeux, R. (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348, 429-432
12. Henderson, V. W. (1997) Estrogen, cognition, and a woman's risk of Alzheimer's disease. Am. J. Med. 103, 11S-18S
13. Birge, S. J. (1997) The role of estrogen in the treatment of Alzheimer's disease. Neurology 48, S36-S41
14. Birge, S. J. (1996) Is there a role for estrogcn replacement therapy in the prevention and treatment of dementia? J. Am. Geriatr. Soc. 44, 865-870
15. Singer, C. A., Rogers, K. L., Strickland, T. M., and Dorsa, D. M. (1996) Estrogen protects primary cortical neurons from glutamate toxicity. Nuerosci. Lett. 212, 13-16
16. Weaver, C. E., Jr., Park-Chung, M., Gibbs, T. T., and Farb, D. H. (1997) 17β-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of XMDA receptors. Brain Res. 761, 338-341
17. Behl, C., Skutella, T., Lezoualc'h, F., Post, A., Widmann, M., Newton, C. J., and Holsboer, F. (1997) Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51, 535-541
18. Green, P. S., Gridley, K. E., and Simpkins, J. W. (1996) Estradiol protects against β-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci. Lett. 218, 165-168
19. Green, P. S., Gridley, K. E., and Simpkins, J. W. (1998) Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione. Neuroscience 84, 7-10
20. Sawada, H., Ibi, M, Kihara, T., Urushitani, M., Akaike, A., and Shimohama, S. (1998) Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death. J. Neurosci. Res. 54, 707-719
21. Gridley, K. E., Green, P. S., and Simpkins, J. W. (1998) A novel, synergistic interaction between 17 β-estradiol and glutathione in the protection of neurons against β-amyloid 25-35-induced toxicity in vitro. Mol. Pharmacol. 54, 874-880
22. Singer, C. A., Figueroa-Masot, X. A., Batchelor, R. H., and Dorsa, D. M. (1999) The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J. Neurosci. 19, 2455-2463
23. Singh, M., Setalo, G., Jr., Guan, X., Warren, M., and Toran-Allerand, C. D. (1999) Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J. Neurosci. 19, 1179-1188
24. Watters, J. J., Campbell, J. S., Cunningham, M. J., Krebs, E. G., and Dorsa, D. M. (1997) Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 138, 4030-4033
25. Sawada, H., and Shimohama, S. (2000). Neuroprotective effecs of estradiol in mesencephalic dopaminergic neurons. Neurosci. Biobehav. Rev. 24, 143-147
26. Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J. A. (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93, 5925-5930
27. Paech, K., Webb, P., Kuiper, G. G., Nilsson, S., Gustafsson, J., Kushner, P. J., and Scanlan, T. S. (1997) Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277, 1508-1510
28. Shughrue, P. J., Lane, M. V., and Merchenthaler, I. (1997) Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system. J. Comp. Neurol. 388, 507-525
29. Kuiper, G. G., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., and Gustafsson, J. A. (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138, 863-870
30. Sawai, H., Okazaki, T., Yamamoto, H., Okano, H., Takeda, Y., Tashima, M., Sawada, H., Okuma, M., Ishikura, H., and Umehara, H. (1995) Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J. Biol. Chem. 270, 27326-27331
31. Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A., and Green, D. R. (1998) DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κ B and AP-1. Mol Cell 1, 543-551
32. Griffith, O. W., and Meister, A. (1979) Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J. Biol. Chem. 254, 7558-7560
33. Griffith, O. W., and Meister, A. (1979) Glutathione: interorgan translocation, turnover, and metabolism. Proc. Natl. Acad. Sci. USA 76, 5606-5610
34. Ambani, L. M., Van Woert, M. H., and Murphy, S. (1975) Brain peroxidase and catalase in Parkinson disease. Arch. Neurol. 32, 114-118
35. Perry, T. L., Godin, D. V., and Hansen, S. (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33, 305-310
36. Kish, S. J., Morito, C., and Hornvkiewicz, O. (1985) Glutathione peroxidase activity in Parkinson's disease brain. Neurosci. Lett. 58, 343-346
37. Caspary, W. J., Lanzo, D. A., and Niziak, C. (1982) Effect of deoxyribonucleic acid on the production of reduced oxygen by bleomycin and iron. Biochemistry 21, 334-338
38. Li, Y., Maher, P., and Schubert, D. (1997) Requirement for cGMP in nerve cell death caused by glutathione depletion. J. Cell Biol. 139, 1317-1324
39. Higuchi, Y., and Matsukawa, S. (1997) Appearance of 1-2 Mbp giant DNA fragments as an early common response leading to cell death induced by various substances that cause oxidative stress. Free Rad. Biol. Med. 23, 90-99
40. Marini, M., Musiani, D., Sestili, P., and Cantoni, O. (1996) Apoptosis of human lymphocytes in the absence or presence of internucleosomal DNA cleavage. Biochem. Biophys. Res. Commun. 229, 910-915
41. Hamilton, R. F., Jr., Li, L., Felder, T. B., and Holian, A. (1995) Bleomycin induces apoptosis in human alveolar macrophages. Am. J. Physiol. 269, L318-L325
42. Rano, T. A., Timkey, T., Peterson, E. P., Rotonda, J., Nicholson, D. W., Becker, J. W., Chapman, K. T., and Thornberry, N. A. (1997) A combinatorial approach for determining protease specificities: application to interleukin-1β converting enzyme (ICE). Chem. Biol. 4, 149-155
43. Hirata, H., Takahashi, A., Kobayashi, S., Yonehara, S., Sawai, H., Okazaki, T., Yamamoto, K., and Sasada, M. (1998) Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J. Exp. Med. 187, 587-600
44. Sawada, H., Kawamura, T., Shimohama, S., Akaike, A., and Kimura, J. (1996) Different mechanisms of glutamate-induced neuronal death between dopaminergic and non-dopaminergic neurons in rat mesencephalic culture. J. Neurosci. Res. 43, 503-510
45. Sawada, H., Shimohama, S., Kawamura, T., Akaike, A., Kitamura, Y., Taniguchi, T., and Kimura, J. (1996) Mechanism of resistance to NO-induced neurotoxicity in cultured rat dopaminergic neurons. J. Neurosci. Res. 46, 509-518
46. Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A., Kimura, J., and Shimohama, S. (1998) Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress. Ann. Neurol. 44, 110-119
47. Bayne, K. (1996) Revised Guide for the Care and Use of Laboratory Animals available. Physiologist 39, 199 208-199
48. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501
49. Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Nakanishi, M., Akaike, A., and Shimohama, S. (2000) Neuroprotective mechanism of GDNF in mesencephalic neurons. J. Neurochem. 74, 1175-1184
50. Charriaut-Mailangue, C., and Ben-Ari, Y. (1995) A cautionary note on the use of the TUNEL stain to determine apoptosis. NeuroReport 7, 61-64
51. Rink, A., Fung, K. M., Trojanowski, J. Q., Lee, V. M., Neugebauer, E., and McIntosh, T. K. (1995) Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am. J. Pathol, 147, 1575-1583
52. Grasl-Kraupp, B., Ruttkay-Nedecky, B., Koudelka, H., Bukowska, K., Bursch, W., and Schulte-Hermann, R. (1995) In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 21, 1465-1468
53. Saraste, A. (1999) Morphologic criteria and detection of apoptosis. Herz 24, 189-195
54. Sengpiel, B., Preis, E., Krieglstein, J., and Prehn, J. H. (1998) NMDA-induced superoxide production and neurotoxicity in cultured rat hippocampal neurons: role of mitochondria. Eur. J. Neurosci. 10, 1903-1910
55. Tan, S., Sahara, Y., Liu, Y., Maher, P., and Schubert, D. (1998) The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. 141, 1423-1432
56. Matsura, T., Kai, M., Fujii, Y., Ito, H., and Yamada, K. (1999) Hydrogen peroxide-induced apoptosis in HL-60 cells requires caspase-3 activation. Free Rad. Res. 30, 73-83
57. Enari, M., Talanian, R. V., Wong, W. W., and Nagata, S. (1996) Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (London) 380, 723-726
58. Ishikawa, Y., Yokoo, T., and Kitamura, M. (1997) c:Jun/AP-1, but not NF-κ B, is a mediator for oxidant-initiated apoptosis in glomerular mesangial cells. Biochem. Biophys. Res. Commun. 240, 496-501
59. Amato, S. F., Swart, J. M., Berg, M., Wanebo, H. J., Mehta, S. R., and Chiles, T. C. (1998) Transient stimulation of the c-Jun-NH2-terminal kinase/activator protein 1 pathway and inhibition of extracellular signal-regulated kinase are early effects in paclitaxel-mediated apoptosis in human B lymphoblasts. Cancer Res. 58, 241-247
60. Liebermann, D. A., Gregory, B., and Hoffman, B. (1998) AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis. Int. J. Oncol. 12, 685-700
61. Jacobs-Helber, S. M., Wickrema, A., Birrer, M. J., and Sawyer, S. T. (1998) AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells. Mol. Cell. Biol. 18, 3699-3707
62. Watabe, M., Ito, K., Masuda, Y., Nakajo, S., and Nakaya, K. (1998) Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells. Oncogene 16, 779-787
63. Srivastava, R. K., Sollott, S. J., Khan, L., Hansford, R., Lakatta, E. G., and Longo, D. L. (1999) Bcl-2 and Bcl-X(L) block thapsigargin-induced nitric oxide generation, c-Jun NH(2)-terminal kinase activity, and apoptosis. Mol. Cell. Biol. 19, 5659-5674
64. Singer, C. A., Rogers, K. L., and Dorsa, D. M. (1998) Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons. NeuroReport 9, 2565-2568
65. Garcia-Segura, L. M., Cardona-Gomez, P., Naftolin, F., and Chowen, J. A. (1998) Estradiol upregulates Bcl-2 expression in adult brain neurons. NeuroReport 9, 593-597
66. Dubal, D. B., Shughrue, P. J., Wilson, M. E., Merchenthaler, I., and Wise, P. M. (1999) Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J. Neurosci. 19, 6385-6393
67. Barkhem, T., Carlsson, B., Nilsson, Y., Enmark, E., Gustafsson, J., and Nilsson, S. (1998) Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/ antagonists. Mol. Pharmacol. 54, 105-112
68. Arnold, S. F., and Notides, A. C. (1995) An antiestrogen: a phophotyrosyl peptide that blocks dimerization of the human estrogen receptor. Proc. Natl. Acad. Sci. USA 92, 7475-7479
69. D'Mello, S. R., Kuan, C.-Y., Flavell, R. A., and Rakic, P. Caspase-3 is required for apoptosis-associatecl DNA fragmentation but not for cell death in neurons deprived of potassium. J. Neurosci. Res. In press
70. Pike, B. R., Zhao, X., Newcomb, J. K., Wang, K. K., Posmantur, R. M., and Hayes, R. L. (1998) Temporal relationships between de novo protein synthesis, calpain and caspase 3-like protease activation, and DNA fragmentation during apoptosis in septohippocampal cultures. J. Neurosci. Res. 52, 505-520
71. Green, P. S., Bishop, J., and Simpkins, J. W. (1997) 17 α-Estradiol exerts neuroprotective effects on SK-N-SH cells. J. Neurosci. 17, 511-515
72. Clark, J. H., Schrader, W. T., and O'Malley, B. W. (1992) Mechanisms of action of steroid hormones. In Textbook of Endocrinology (Wilson, J., and Foster, D. W., eds) pp 35-90, W.B. Saunders Company, Philadelphia